Behavioural beliefs: advantages | Normative beliefs: approving individuals |
Altruism (n=15) | Self (n=11) |
Improve SLE knowledge | Family and friends (n=6) |
New drug discovery | Religious groups (n=4) |
Heterogeneity of drug effects | Normative beliefs: disapproving individuals |
Personal benefit (n=12) | Family (n=9) |
Access to medications | |
Thorough care | Control beliefs: facilitators |
Free care | Flexibility in scheduling (n=12) |
Behavioural beliefs: disadvantages | Advanced notice (n=11) |
Unknown aspects (n=22) | Ease of consent and patient forms (n=9) |
Receipt of placebo | Hope for SLE improvement (n=4) |
Side effects (short and long term) | Control beliefs: barriers |
Efficacy | Logistics (n=9) |
Risk of flare | Time (n=7) |
Disappointment (n=18) | |
Exclusion (comorbidities, disease activity) | |
Withdrawal of care | |
Inadequate feedback | |
Information burden (n=15) | |
Lengthy forms | |
Redundant forms | |
Medical and legal jargon | |
Life–health balance (n=8) | |
Time commitment | |
Care of children or other family members | |
Frequency and length of appointments | |